Belgium becomes the next European Nation to recognize the Covishield vaccine which is produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University. Speaking about this, The Embassy of Belgium announced the same.
The embassy of Belgium tweeted stating that Belgium recognizes covishield the @AstraZeneca vaccine produced by @SerumInstIndia and distributed by COVAX. An important decision for India, Nepal, Bhutan, Sri Lanka, Maldives, Bangladesh in the fight against vaccine inequality.
Earlier this week, the Netherlands approved covishield vaccine for travellers.
Apart from this week, Switzerland, Iceland and 7 other EU nations have recognized the vaccine on July 01, this comes after a day where External Affairs Minister S Jaishankar had taken up the matter with the European bloc. As of now, Austria, Greece, Germany, Slovenia, Ireland, Iceland, Spain, and Estonia have recognised the SII-manufactured vaccine.
Authorities in India have called on the European Union Member states to individually consider extending the exemption to all persons, who have received Covishield and Covaxin vaccines while stressing that they will also introduce a reciprocal policy to recognise the EU Digital COVID Certificate.
Joining Belgium, currently, 15 countries now approve the Covishield covid-19 vaccine.
India has also urged the EU to accept the vaccination certificates that are being issued via India’s CoWIN portal.
Currently, the EU green pass or European Union Digital Covid certificate has only 4 vaccines listed and none of them is India made vaccines as of now.